We are live on
!
Find out more
ClearBridge Investments Portfolio holdings
AUM
$115B
1-Year Est. Return
24.78%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+24.78%
3 Year Est. Return
+90.16%
5 Year Est. Return
+117.12%
10 Year Est. Return
+468.76%
AUM
$65.5B
AUM Growth
–
Cap. Flow
+$64.9B
Cap. Flow
% of AUM
99.09%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
1,063
New
1,037
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.77B |
| 2 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$1.58B |
| 3 |
UnitedHealth
UNH
|
+$1.56B |
| 4 |
APC
Anadarko Petroleum
APC
|
+$1.16B |
| 5 |
Johnson & Johnson
JNJ
|
+$859M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 16.44% |
| 2 | Healthcare | 16.17% |
| 3 | Technology | 14.01% |
| 4 | Industrials | 9.96% |
| 5 | Financials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDR
1026
DELISTED
McDermott International
MDR
| $4K | ﹤0.01% |
+151
| New | +$4.37K |
|
1027
Advanced Micro Devices
AMD
$776B
| $3K | ﹤0.01% |
+600
| New | +$2.08K |
|
|
PTNR
1028
DELISTED
Partner Communications
PTNR
| $3K | ﹤0.01% |
+400
| New | +$2.63K |
|
|
MAKO
1029
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $3K | ﹤0.01% |
+200
| New | +$2.27K |
|
1030
Boston Scientific
BSX
$69.5B
| $2K | ﹤0.01% |
+215
| New | +$1.82K |
|
|
REE
1031
DELISTED
RARE ELEMENT RES LTD
REE
| $2K | ﹤0.01% |
+1,000
| New | +$1.95K |
|
|
VELT
1032
DELISTED
VELTI PLC, ST HELIER ORDINARY SHARES (JERSEY)
VELT
| $2K | ﹤0.01% |
+1,200
| New | +$2.14K |
|
1033
ANI Pharmaceuticals
ANIP
$1.8B
| $1K | ﹤0.01% |
+25
| New | +$175 |
|
|
PDLI
1034
DELISTED
PDL BioPharma, Inc.
PDLI
| $1K | ﹤0.01% |
+101
| New | +$788 |
|
Similar funds
VAM
ClearBridge Investments's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for ClearBridge Investments, which disclosed 1,063 positions worth $65.5B. Its ten largest holdings account for 17% of the portfolio.
Its largest position is Biogen: 8,265,256 shares worth $1.78B.
By sector, the portfolio is most concentrated in Energy at 16% of assets, followed by Healthcare and Technology.
- ClearBridge Investments's largest Q2 2013 buy was Biogen: 8,265,256 shares worth $1.78B.
- ClearBridge Investments's ten largest holdings make up 17% of its $65.5B portfolio in Q2 2013.
- ClearBridge Investments disclosed 1,063 positions in Q2 2013, its first 13F filing on record.
Based on ClearBridge Investments's 13F filing for Q2 2013, filed 14 Aug 2013.